Efficacy of the Novel Degludec/Aspart Insulin Co-formulation in Children and Adolescents with Type 1 Diabetes: A Real-life Experience with One Year of IDegAsp Therapy in Poorly Controlled and Non-compliant Patients

OBJECTIVE: To evaluate the efficacy of degludec/aspart (IDegAsp) insulin co-formulation in children and adolescents with poorly controlled type 1 diabetes (T1DM). METHODS: Patients with poorly controlled T1DM on basal-bolus insulin regimes and having compliance problems related to insulin injections...

Descripción completa

Detalles Bibliográficos
Autores principales: Kırkgöz, Tarık, Eltan, Mehmet, Kaygusuz, Sare Betül, Yavaş Abalı, Zehra, Helvacıoğlu, Didem, Seven Menevşe, Tuba, Gürpınar Tosun, Büşra, Güran, Tülay, Bereket, Abdullah, Turan, Serap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900081/
https://www.ncbi.nlm.nih.gov/pubmed/34355879
http://dx.doi.org/10.4274/jcrpe.galenos.2021.2021.0113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900081/
https://www.ncbi.nlm.nih.gov/pubmed/34355879
http://dx.doi.org/10.4274/jcrpe.galenos.2021.2021.0113

Ejemplares similares